Incidence, features, and outcome of disease relapse after COVID-19 vaccination in patients with idiopathic inflammatory myopathies.

Melinda Nagy-VinczeTibor BéldiKatalin SzabóAnett VinczeBalázs Miltényi-SzabóZsófia VargaJózsef Varga Zoltán Griger

Published in: Muscle & nerve (2023)

A minority of the vaccinated IIM patients had a confirmed disease flare after COVID-19 vaccination and the majority of the relapses improved after individualized treatment. An active disease state at the time of vaccination probably contributes to the increased risk of a post vaccination myositis flare.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
oxidative stress
prognostic factors
free survival
patient reported
replacement therapy